Log In
Print
BCIQ
Print
Print this Print this
 

Prezista, darunavir

Also known as: TMC114

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionSecond-generation protease inhibitor
Molecular Target HIV protease
Mechanism of ActionHIV protease inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat HIV infection in treatment-experienced children and adolescents above the age of 6; Treat HIV infection in treatment-experienced patients; Treat HIV infection in treatment-naïve patients; Treat HIV-1 infection in pediatric patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today